You are here

Article Text

Article menu
Download PDFPDF
Commentary
Provision and standards of care for treatment and follow-up of patients with auto-immune hepatitis (AIH)

https://doi.org/10.1136/flgastro-2021-101928

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors I am the sole author, and the opinion expressed in the commentary is mine alone.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests I have served on Advisory Boards for Dr Falk PharmaceuticalsI have lectured on autoimmune liver disease in meetings sponsored by Dr Falk Pharmaceuticals.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Linked Articles

    • Liver
      Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)
      Victoria Mary Gordon Ratul Adhikary Guruprasad P Aithal Victoria Appleby Debasish Das James Day Toby Delahooke Selena Dixon David Elphick Claire Hardie Michael Heneghan Barbara Hoeroldt Patricia Hooper John Hutchinson Rebecca L Jones Faisal Khan Jane Metcalf Alick Nkhoma Stavroula Pelitari Martin Prince Annell Prosser Sushma Saksena Vinay Sathyanarayana Deven Vani Andrew Yeoman Dermot Gleeson
      Frontline Gastroenterology 2021; 13 126-132 Published Online First: 18 May 2021. doi: 10.1136/flgastro-2020-101661